Cargando…
The modern role of androgen deprivation therapy in the management of localised and locally advanced prostate cancer
INTRODUCTION: Approximately 50% of men diagnosed with prostate cancer will be exposed to androgen deprivation therapy (ADT) at some stage. The role of ADT in the management of metastatic disease has long been recognised, and its place in the management of localised and locally advanced disease has b...
Autores principales: | Gunner, Charlotte, Gulamhusein, Aziz, Rosario, Derek J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356175/ https://www.ncbi.nlm.nih.gov/pubmed/28344813 http://dx.doi.org/10.1177/2051415816654048 |
Ejemplares similares
-
Novel biomarkers for the detection of prostate cancer
por: Jakobsen, Niels Asger, et al.
Publicado: (2016) -
Novel concepts for risk stratification in prostate cancer
por: Patel, Keval M, et al.
Publicado: (2016) -
The role of imaging in the diagnosis of primary prostate cancer
por: Harvey, Hugh, et al.
Publicado: (2016) -
The role of chemotherapy and new targeted agents in the management of primary prostate cancer
por: Kumar, Sanjeev Srinivas, et al.
Publicado: (2016) -
Characteristics of Patients in SPCG-15—A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate Cancer
por: Gongora, Magdalena, et al.
Publicado: (2022)